Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure

Foley, Robert N · 2003 · Seminars in Dialysis

Abstract

Patients with end‐stage renal disease (ESRD) are at extreme cardiovascular risk. At least half of all patients starting dialysis therapy have overt cardiovascular disease (CVD). In addition, recent studies suggest annual incidence rates for new‐onset cardiac failure, peripheral vascular disease, ischemic heart disease (IHD), and stroke of approximately 7%, 7%, 5%, and 1%, respectively. High‐level exposure to traditional risk factors, such as smoking and dyslipidemia, hemodynamic overload factors, such as anemia and hypertension, and a myriad of metabolic factors related to uremia are all likely to play a role. There has been explosive growth in observational studies and a heartening, if less dramatic, increase in risk factor intervention trials, suggesting that risk factor modification can lead to meaningful benefit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1525-139x.2003.160271.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 67

  1. FoleyRN HerzogCA CollinsAJ:Smoking and cardiovascular outcomes in dialysis patients. The United States Renal Data System Wave 2 Study.Kidney Int:(in press) 2002
  2. 10.1038/ki.1995.22 · DOI · Paper page
  3. 10.1681/ASN.V12122759 · DOI · Paper page
  4. 10.1681/ASN.V12122768 · DOI · Paper page
  5. 10.1001/jama.268.12.1545 · DOI
  6. 10.1046/j.1523-1755.2002.00362.x · DOI
  7. 10.1097/00007890-200107150-00021 · doi:10.1097/00007890-200107150-00021
  8. 10.1097/00007890-199511150-00005 · DOI
  9. 10.1097/00007890-200008270-00006 · DOI
  10. 10.1097/00007890-200207150-00013 · DOI
  11. Foley RN, 2000, Serial change in echocardiographic parameters and cardiac failure in end‐stage renal disease, J Am Soc Nephrol, 11, 912, 10.1681/ASN.V115912 · DOI · Paper page
  12. 1992, Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients, Am J Kidney Dis, 20, 32
  13. 10.1038/ki.1995.132 · DOI · Paper page
  14. Tonelli M, 2001, Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency, Am J Kidney Dis, 37, 484, 10.1053/ajkd.2001.22070 · doi:10.1053/ajkd.2001.22070 · Paper page
  15. 10.1038/ki.1996.349 · doi:10.1038/ki.1996.349
  16. 10.1681/ASN.V114753 · DOI · Paper page
  17. 10.1097/01.ASN.0000018401.82863.FD · DOI · Paper page
  18. 10.2337/diacare.25.4.742 · DOI · Paper page
  19. 10.1016/S0002-9149(99)80683-3 · DOI · Paper page
  20. 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  21. Manske CL, 1992, Prevalence of and risk factors for angiographically determined coronary artery disease in type I‐diabetic patients with nephropathy, Arch Intern Med, 152, 2450, 10.1001/archinte.1992.00400240070012 · doi:10.1001/archinte.1992.00400240070012
  22. 10.1016/S0140-6736(94)92935-1 · DOI · Paper page
  23. 10.1177/096368970000900617 · DOI
  24. 10.1016/S0140-6736(98)04433-X · DOI · Paper page
  25. 10.1056/NEJM199604113341502 · DOI · Paper page
  26. 10.1056/NEJM198706043162301 · DOI · Paper page
  27. Cleland JG, 1997, Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators, Eur Heart J, 18, 41, 10.1093/eurheartj/18.1.41 · DOI
  28. U.S. Renal Data System:, 1992, USRDS 1992 annual report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients, Am J Kidney Dis, 32
  29. 10.1016/S0272-6386(12)70364-5 · DOI · Paper page
  30. 10.1038/ki.1996.194 · DOI · Paper page
  31. 10.1053/ajkd.2000.19100 · DOI
  32. 10.1093/ndt/12.4.724 · DOI
  33. 10.1016/S0272-6386(99)70187-3 · DOI · Paper page
  34. 10.1016/S0272-6386(96)90309-1 · doi:10.1016/s0272-6386(96)90309-1
  35. 10.1093/ndt/14.11.2599 · doi:10.1093/ndt/14.11.2599
  36. 10.1053/ajkd.2001.26103 · DOI · Paper page
  37. 10.1161/01.CIR.90.6.2786 · DOI · Paper page
  38. 10.1016/S0895-7061(00)01232-2 · DOI · Paper page
  39. 10.1046/j.1523-1755.2002.00173.x · DOI · Paper page
  40. 10.1001/jama.287.12.1548 · DOI · Paper page
  41. 10.1046/j.1523-1755.2002.00636.x · DOI · Paper page
  42. 10.1038/ki.1996.355 · DOI · Paper page
  43. 10.1161/01.CIR.86.2.475 · DOI · Paper page
  44. 10.1016/S0272-6386(12)70189-0 · doi:10.1016/s0272-6386(12)70189-0
  45. 10.1046/j.1523-1755.1999.07158.x · DOI
  46. Baigent C, 2001, Efficacy and safety of simvastatin and low‐dose aspirin among patients with chronic renal disease: the UK‐Heart and Renal Protection (UK‐HARP) pilot study [abstract], J Am Soc Nephrol, 12, 190A
  47. Tonelli M, 2001, Pravastatin is effective for secondary prevention of cardiovascular events in patients with chronic renal insufficiency [abstract], J Am Soc Nephrol, 12, 252A
  48. 10.1016/0272-6386(95)90645-2 · DOI
  49. 10.1016/S0272-6386(99)70118-6 · DOI · Paper page
  50. 10.1016/S0272-6386(96)90130-4 · DOI · Paper page
  51. 10.1681/ASN.V8121921 · DOI · Paper page
  52. 10.1681/ASN.V103610 · DOI · Paper page
  53. 10.7326/0003-4819-121-5-199409010-00009 · DOI · Paper page
  54. 10.1056/NEJM199910213411706 · DOI · Paper page
  55. 10.1046/j.1523-1755.2000.00289.x · DOI · Paper page
  56. 10.1093/ndt/14.5.1182 · doi:10.1093/ndt/14.5.1182
  57. 10.1093/ndt/15.9.1425 · DOI
  58. Middleton RJ, 2001, Left ventricular hypertrophy in the renal patient, J Am Soc Nephrol, 12, 1079, 10.1681/ASN.V1251079 · DOI · Paper page
  59. 10.1038/ki.1987.94 · DOI · Paper page
  60. 10.1053/ajkd.1998.v31.pm9531176 · DOI · Paper page
  61. 10.1093/ndt/15.7.1014 · DOI · Paper page
  62. 10.1046/j.1523-1755.2002.00434.x · DOI · Paper page
  63. 10.1016/S0272-6386(00)70200-9 · DOI · Paper page
  64. Foley RN, 1996, Hypoalbuminemia, cardiac morbidity, and mortality in end‐stage renal disease, J Am Soc Nephrol, 7, 728, 10.1681/ASN.V75728 · DOI · Paper page
  65. 10.1681/ASN.V1271549 · DOI · Paper page
  66. 10.1016/S0140-6736(00)02783-5 · DOI · Paper page
  67. 10.1681/ASN.V104891 · DOI · Paper page

Cited by

See all 171

Metadata

Authors
Foley, R. N.
Venue
Seminars in Dialysis
Publisher
Wiley
Published
2003-03
Volume
16
Issue
2
Pages
111-117
ISSN
  • 0894-0959 (ISSN-L)
  • 1525-139X
OpenAlex
W2107703251
Cited by
171
References
7
FWCI
5.64
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure. https://app.cochat.ai/papers/10.1046/j.1525-139x.2003.160271.x
The paper
Foley, R. N. (2003). THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure. Seminars in Dialysis. https://doi.org/10.1046/j.1525-139x.2003.160271.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.